2014 Q2 Form 10-Q Financial Statement

#000110465914037299 Filed on May 12, 2014

View on sec.gov

Income Statement

Concept 2014 Q2 2014 Q1 2013 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.050M $2.630M $3.090M
YoY Change 13.81% -12.91% 8.04%
% of Gross Profit
Research & Development $7.890M $6.360M $6.088M
YoY Change -22.18% -33.85% -39.43%
% of Gross Profit
Depreciation & Amortization $40.00K $33.00K $50.00K
YoY Change -63.64% -78.0% -66.67%
% of Gross Profit
Operating Expenses $10.95M $8.989M $9.179M
YoY Change -14.61% -28.87% -28.89%
Operating Profit -$8.989M -$9.179M
YoY Change -28.87% -28.89%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00 $2.000K $1.389M
YoY Change -100.0% -96.36% -4309.09%
Pretax Income -$10.94M -$8.990M -$7.790M
YoY Change -14.54% -28.55% -39.81%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.94M -$8.987M -$7.790M
YoY Change -14.53% -28.57% -27.3%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$1.451M -$1.352M -$1.301M
COMMON SHARES
Basic Shares Outstanding 75.16M shares 75.16M shares 63.19M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q2 2014 Q1 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.30M $27.80M $14.70M
YoY Change -45.25% -34.12% -73.8%
Cash & Equivalents $11.20M $22.43M $14.53M
Short-Term Investments $6.100M $5.300M $200.0K
Other Short-Term Assets $1.200M $1.300M $400.0K
YoY Change 20.0% -7.14% -42.86%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $18.50M $29.06M $15.17M
YoY Change -43.25% -33.35% -73.3%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $86.00K $112.0K
YoY Change -66.67% -77.89% -77.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $600.0K $738.0K $434.0K
YoY Change -33.33% -33.03% -54.74%
TOTAL ASSETS
Total Short-Term Assets $18.50M $29.06M $15.17M
Total Long-Term Assets $600.0K $738.0K $434.0K
Total Assets $19.10M $29.79M $15.61M
YoY Change -42.99% -33.35% -72.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.000M $619.0K $808.0K
YoY Change -44.44% -43.73% -52.67%
Accrued Expenses $2.700M $3.900M $3.800M
YoY Change -58.46% -44.29% -51.28%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.700M $4.513M $4.567M
YoY Change -55.42% -44.62% -51.9%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.0K $195.0K $354.0K
YoY Change -75.0% -60.04% -38.75%
Total Long-Term Liabilities $100.0K $195.0K $354.0K
YoY Change -75.0% -60.04% -38.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.700M $4.513M $4.567M
Total Long-Term Liabilities $100.0K $195.0K $354.0K
Total Liabilities $3.900M $4.708M $4.921M
YoY Change -55.17% -45.49% -51.15%
SHAREHOLDERS EQUITY
Retained Earnings -$464.3M -$455.4M
YoY Change 9.04% 10.19%
Common Stock $489.4M $466.0M
YoY Change 5.96% 1.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $15.30M $25.09M $10.68M
YoY Change
Total Liabilities & Shareholders Equity $19.10M $29.79M $15.61M
YoY Change -42.99% -33.35% -72.99%

Cashflow Statement

Concept 2014 Q2 2014 Q1 2013 Q4
OPERATING ACTIVITIES
Net Income -$10.94M -$8.987M -$7.790M
YoY Change -14.53% -28.57% -27.3%
Depreciation, Depletion And Amortization $40.00K $33.00K $50.00K
YoY Change -63.64% -78.0% -66.67%
Cash From Operating Activities -$9.890M -$8.087M -$7.650M
YoY Change -12.94% -41.92% -24.03%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $4.000K $0.00
YoY Change -86.21% -100.0%
Acquisitions
YoY Change
Other Investing Activities -$730.0K -$5.150M $2.900M
YoY Change -127.04% -362.76% -85.06%
Cash From Investing Activities -$730.0K -$5.149M $2.900M
YoY Change -127.14% -366.65% -85.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -620.0K $21.14M 0.000
YoY Change -178.48% 25065.48% -100.0%
NET CHANGE
Cash From Operating Activities -9.890M -$8.087M -7.650M
Cash From Investing Activities -730.0K -$5.149M 2.900M
Cash From Financing Activities -620.0K $21.14M 0.000
Net Change In Cash -11.24M $7.903M -4.750M
YoY Change 42.64% -166.37% -151.08%
FREE CASH FLOW
Cash From Operating Activities -$9.890M -$8.087M -$7.650M
Capital Expenditures $0.00 $4.000K $0.00
Free Cash Flow -$9.890M -$8.091M -$7.650M
YoY Change -12.94% -42.01% -23.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 gtxi Accrual For Product Returns Included In Other Long Term Liabilities
AccrualForProductReturnsIncludedInOtherLongTermLiabilities
332000 USD
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10382571 shares
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29793000 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15605000 USD
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 0.2in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of condensed financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the condensed financial statements, and the reported amounts of revenues and expenses during the reporting period.&#160; Actual amounts and results could differ from those estimates.</font></p> <p style="TEXT-INDENT: 0.2in; MARGIN: 0in 0in 0pt;">&#160;</p> </div>
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6680423 shares
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
75000 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
63000 USD
CY2014Q1 us-gaap Revenue Recognition Sales Of Goods
RevenueRecognitionSalesOfGoods
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">FARESTON</font></i></b><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">&#174;</font><b><i><font style="FONT-STYLE: italic; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">&#160;Revenue Recognition</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;">&#160;</p> <p style="TEXT-INDENT: 13.7pt; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Although the Company sold its rights and certain assets related to FARESTON</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">&#174;</font><font style="FONT-SIZE: 10pt;" size="2">&#160;effective September 30, 2012, the Company retained the liability for future product returns relating to sales of FARESTON</font><font style="POSITION: relative; FONT-SIZE: 6.5pt; TOP: -3pt;" size="1">&#174;</font><font style="FONT-SIZE: 10pt;" size="2">&#160;made by the Company prior to September 30, 2012.&#160; Therefore, the Company estimates an accrual for product returns based on factors which include historical product returns and estimated product in the distribution channel which is expected to exceed its expiration date.&#160; At March 31, 2014 and December 31, 2013, the Company&#8217;s accrual for product returns, was $454 and $918, respectively.&#160; Of these amounts, $189 and $332 have been included in &#8220;Other long-term liabilities&#8221; in the condensed balance sheet at March 31, 2014 and December 31, 2013, respectively, and represents the portion of the Company&#8217;s product returns accrual estimated to be payable after one year.&#160; The accrual for product returns decreased during the current period due to the closure of the return period for a portion of the previously sold inventory.</font></p> <p style="TEXT-INDENT: 13.7pt; MARGIN: 0in 0in 0pt;">&#160;</p> </div>
CY2014Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2014Q1 gtxi Accrual For Product Returns
AccrualForProductReturns
454000 USD
CY2013Q4 gtxi Accrual For Product Returns
AccrualForProductReturns
918000 USD
CY2014Q1 gtxi Accrual For Product Returns Included In Other Long Term Liabilities
AccrualForProductReturnsIncludedInOtherLongTermLiabilities
189000 USD
CY2014Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2247000 USD
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
856000 USD
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.879 pure
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.744 pure
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.023 pure
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.011 pure
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
CY2013Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y6M
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6215809 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6445342 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2000 shares
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
231533 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.58
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.38
CY2014Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.74
CY2014Q1 dei Entity Registrant Name
EntityRegistrantName
GTX INC /DE/
CY2014Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001260990
CY2014Q1 dei Document Type
DocumentType
10-Q
CY2014Q1 dei Document Period End Date
DocumentPeriodEndDate
2014-03-31
CY2014Q1 dei Amendment Flag
AmendmentFlag
false
CY2014Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
75161437 shares
CY2014Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22432000 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14529000 USD
CY2014Q1 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
5345000 USD
CY2013Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
200000 USD
CY2014Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1278000 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
442000 USD
CY2014Q1 us-gaap Assets Current
AssetsCurrent
29055000 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
15171000 USD
CY2014Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
619000 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
808000 USD
CY2014Q1 gtxi Accrued And Other Current Liabilities
AccruedAndOtherCurrentLiabilities
3894000 USD
CY2013Q4 gtxi Accrued And Other Current Liabilities
AccruedAndOtherCurrentLiabilities
3759000 USD
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
86000 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
112000 USD
CY2014Q1 gtxi Intangible And Other Assets
IntangibleAndOtherAssets
652000 USD
CY2013Q4 gtxi Intangible And Other Assets
IntangibleAndOtherAssets
322000 USD
CY2014Q1 us-gaap Assets
Assets
29793000 USD
CY2013Q4 us-gaap Assets
Assets
15605000 USD
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4513000 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4567000 USD
CY2014Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
195000 USD
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
354000 USD
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
489357000 USD
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
465981000 USD
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-464347000 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-455360000 USD
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
25085000 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
10684000 USD
CY2014Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75161437 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
63185389 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
75161437 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
63185389 shares
CY2014Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
6360000 USD
CY2013Q1 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
9614000 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2629000 USD
CY2013Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3023000 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
8989000 USD
CY2013Q1 us-gaap Operating Expenses
OperatingExpenses
12637000 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-8989000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-12637000 USD
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 USD
CY2013Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
55000 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-8987000 USD
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-12582000 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
66512069 shares
CY2013Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
62864140 shares
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33000 USD
CY2013Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
150000 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2215000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
814000 USD
CY2014Q1 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
32000 USD
CY2013Q1 us-gaap Deferred Compensation Arrangement With Individual Compensation Expense
DeferredCompensationArrangementWithIndividualCompensationExpense
42000 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1169000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
913000 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-189000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-607000 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-22000 USD
CY2013Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-827000 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4000 USD
CY2013Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
29000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8087000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13923000 USD
CY2014Q1 us-gaap Payments For Proceeds From Heldtomaturity Securities Shortterm
PaymentsForProceedsFromHeldtomaturitySecuritiesShortterm
5145000 USD
CY2013Q1 us-gaap Payments For Proceeds From Heldtomaturity Securities Shortterm
PaymentsForProceedsFromHeldtomaturitySecuritiesShortterm
1225000 USD
CY2013Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
3185000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5149000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1931000 USD
CY2014Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2000 USD
CY2013Q1 us-gaap Repayments Of Long Term Debt And Capital Securities
RepaymentsOfLongTermDebtAndCapitalSecurities
2000 USD
CY2013Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
86000 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
21139000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
84000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36136000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48044000 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
7903000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11908000 USD
CY2014Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
21141000 USD

Files In Submission

Name View Source Status
0001104659-14-037299-index-headers.html Edgar Link pending
0001104659-14-037299-index.html Edgar Link pending
0001104659-14-037299.txt Edgar Link pending
0001104659-14-037299-xbrl.zip Edgar Link pending
a14-9548_110q.htm Edgar Link pending
a14-9548_1ex10d1.htm Edgar Link pending
a14-9548_1ex10d2.htm Edgar Link pending
a14-9548_1ex10d3.htm Edgar Link pending
a14-9548_1ex31d1.htm Edgar Link pending
a14-9548_1ex31d2.htm Edgar Link pending
a14-9548_1ex32d1.htm Edgar Link pending
a14-9548_1ex32d2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gtxi-20140331.xml Edgar Link completed
gtxi-20140331.xsd Edgar Link pending
gtxi-20140331_cal.xml Edgar Link unprocessable
gtxi-20140331_def.xml Edgar Link unprocessable
gtxi-20140331_lab.xml Edgar Link unprocessable
gtxi-20140331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending